Publications
Individualized Dosing of Therapeutic Monoclonal Antibodies: A Changing Treatment Paradigm?
A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab in Relapse Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Identification of Peptide Mimotope Ligands for Natalizumab
A General Process for the Development of Peptide-Based Immunoassays for Monoclonal Antibodies